2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4365):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-43331
    Bis(acetoxymethyl) 2,2'-((tert-butoxycarbonyl)azanediyl)diacetate
    Bis(acetoxymethyl) 2,2'-((tert-butoxycarbonyl)azanediyl)diacetate is a drug intermediate for synthesis of various active compounds.
    Bis(acetoxymethyl) 2,2'-((tert-butoxycarbonyl)azanediyl)diacetate
  • HY-75204
    2-(3-(Trifluoromethyl)benzamido)acetic acid
    		99.31%
    2-(3-(Trifluoromethyl)benzamido)acetic acid is a drug intermediate for synthesis of various active compounds.
    2-(3-(Trifluoromethyl)benzamido)acetic acid
  • HY-I0530
    Canagliflozin impurity 9
    Canagliflozin impurity 9 is an impurity of Canagliflozin (HY-10451).
    Canagliflozin impurity 9
  • HY-W283704
    Fmoc-(Dmb)Ala-OH
    		98.02%
    Fmoc-(Dmb)Ala-OH is a peptide intermediate and can be used in peptide synthesis.
    Fmoc-(Dmb)Ala-OH
  • HY-75016
    Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
    		99.61%
    Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- is a drug intermediate for synthesis of various active compounds.
    Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
  • HY-Z0684
    3-(2,3-Dihydrobenzofuran-7-yl)acrylic acid
    3-(2,3-Dihydrobenzofuran-7-yl)acrylic acid is a drug impurity.
    3-(2,3-Dihydrobenzofuran-7-yl)acrylic acid
  • HY-W101412
    4-Isobutylpyrrolidin-2-one
    		99.96%
    4-Isobutylpyrrolidin-2-one is a phosphite compound that is commonly used as an intermediate in organic synthesis.
    4-Isobutylpyrrolidin-2-one
  • HY-W006103
    I-bu-rG Phosphoramidite
    		98.0%
    I-bu-rG Phosphoramidite is a phosphoramidite monomer that can be used in the synthesis of nucleotides and nucleic acids.
    I-bu-rG Phosphoramidite
  • HY-136665
    Boc-D-Phe-Pro-OH
    		99.51%
    Boc-D-Phe-Pro-OH (tert-Butoxycarbonyl-D-phenylalanyl-L-proline) is a synthetic intermediate useful for pharmaceutical synthesis.
    Boc-D-Phe-Pro-OH
  • HY-W015332
    Captopril EP Impurity D
    Captopril EP Impurity D is an impurity of Captopril (HY-B0368).
    Captopril EP Impurity D
  • HY-Z3759
    Vonoprazan impurity 7
    Vonoprazan impurity 7 is an impurity of Vonoprazan (HY-100007).
    Vonoprazan impurity 7
  • HY-W043311
    Methyl pyrimidine-4-carboxylate
    		98.96%
    Methyl pyrimidine-4-carboxylate (Pyrimidine-4-carboxylicacidmethylester) is a synthetic intermediate useful for pharmaceutical synthesis.
    Methyl pyrimidine-4-carboxylate
  • HY-75405
    Asenapine impurity 1
    Asenapine impurity 1 is an impurity of Asenapine (HY-10121). Asenapine, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine can be used in the research of schizophrenia and bipolar disorder.
    Asenapine impurity 1
  • HY-400766
    BWA-522 intermediate-2
    		99.87%
    BWA-522 intermediate-2 is a BWA-522 intermediate. BWA-522 is an orally available small molecule protein-targeting chimera (PROTACs) with significant degradation effect on AR-FL and AR-V7.
    BWA-522 intermediate-2
  • HY-W009807
    1-Chloro-3,5-dimethyladamantane
    		99.75%
    1-Chloro-3,5-dimethyladamantane is an Adamantane (HY-N2427) derivative.
    1-Chloro-3,5-dimethyladamantane
  • HY-W059074
    Pantoprazole impurity 42
    		99.79%
    Pantoprazole impurity 42 is an impurity of Pantoprazole (HY-17507).
    Pantoprazole impurity 42
  • HY-Z4533
    Afatinib impurity 6
    Afatinib impurity 6 is an impurity of Afatinib (HY-10261).
    Afatinib impurity 6
  • HY-W039179
    Gabapentin acid impurity 4
    Gabapentin acid impurity 4 is an impurity of Gabapentin acid.
    Gabapentin acid impurity 4
  • HY-W054225
    Aripiprazole impurity 31
    Aripiprazole impurity 31 is an impurity of Aripiprazole.
    Aripiprazole impurity 31
  • HY-204927A
    1-Methyl-N-(4-(piperidin-1-yl)phenyl)-1H-imidazole-4-sulfonamide TFA
    1-Methyl-N-(4-(piperidin-1-yl)phenyl)-1H-imidazole-4-sulfonamide TFA is a pharmaceutical synthesis intermediate.
    1-Methyl-N-(4-(piperidin-1-yl)phenyl)-1H-imidazole-4-sulfonamide TFA